Julie M. Pelletier
Quebec, QC G1V4G2, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Nucleotide-Derived Competitive Inhibitors of Ectonucleotidase CD39─A Promising Extracellular Target for Immunotherapy of Cancer.
Journal: Journal of medicinal chemistry
Published: May 01, 2026
P2Y2 Receptor Controls TLR3-Induced Chemokine Production in Intestinal Epithelial Cells.
Journal: Journal of immunology research
Published: September 22, 2025
Synthesis, biological evaluation and molecular docking studies of N-propylsulfonyl indole-linked hydrazinecarbothioamides as selective ecto-5'-nucleotidase and NTPDase inhibitors.
Journal: Scientific reports
Published: September 10, 2025
Quinoline carboxylic acid derivatives as potent ectonucleotidase inhibitors.
Journal: Scientific reports
Published: June 08, 2025
Synthesis, Biological Evaluation and Molecular Docking Studies of Novel 4-Propylsulfonylpiperazines-Based Thiosemicarbazones as Ecto-5'-Nucleotidase and NTPDase Inhibitors.
Journal: Archiv der Pharmazie
Published: April 26, 2025
HIF-1α Stabilization Hampers the Chondrogenic Differentiation of Aged Bone Marrow Mesenchymal Stem Cells by Adenosine A2A/A2B Receptors Imbalance.
Journal: ACS pharmacology & translational science
Published: March 13, 2025
Synthesis, Characterization, Interactions, and Immunomodulatory Function of Ectonucleotidase CD39/CD73 Inhibitor 8-Butylthioadenosine 5'-Monophosphate.
Journal: ACS pharmacology & translational science
Published: February 14, 2025
Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
Journal: International journal of biological macromolecules
Published: November 08, 2023
Synthesis of new class of indole acetic acid sulfonate derivatives as ectonucleotidases inhibitors.
Journal: RSC advances
Published: June 25, 2023
Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) - a promising target for the immunotherapy of cancer.
Journal: Frontiers in immunology
Published: February 24, 2023
Last Updated: 09/26/2026